Patient info Open main menu

Colofac tablets 135 mg – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
135 mg
Contains active substance:
ATC code:

Patient leaflet - Colofac tablets 135 mg

1. What Colofac Tablets 135 mg are and what they are used for

Colofac Tablets 135 mg contain Mebeverine hydrochloride. This belongs to a group of medicines called antispasmodics.

This medicine is used to treat symptoms of irritable bowel syndrome (IBS) and similar problems such as chronic irritable colon, spastic constipation, mucous colitis and spastic colitis. Irritable bowel syndrome (IBS) is a very common condition which causes spasm and pain in the gut or intestine.

The intestine is a long muscular tube which food passes down so it can be digested. If the intestine goes into spasm and squeezes too tightly, you get pain. The way this medicine works is by relieving the spasm, pain and other symptoms of IBS.

The main symptoms of irritable bowel syndrome (IBS) include:

  • stomach pain and spasm
  • feeling bloated and having wind
  • having diarrhoea (with or without constipation)
  • small, hard, pellet‑like or ribbon‑like stools (faeces)

These symptoms may vary from person to person.

Talk to your doctor if these symptoms do not improve after a while if you develop new symptoms or you are concerned about your symptoms.

Your diet and lifestyle can also help treat IBS:

How you restrict your diet depends on the way IBS affects you. If you find that certain foods bring on the symptoms, then it makes sense not to eat them. A high fibre diet may help, but ask your pharmacist for more information.

Some people find that learning to relax can help to lessen their symptoms of IBS. You may find it helpful to set aside a few moments each day to relax and gently unwind.

2. Before you take Colofac Tablets 135 mg

Do not take Colofac Tablets 135 mg if:

  • You are allergic to any of the tablet ingredients (see section 6 for a list of ingredients).

If any of the above applies to you, do not take this medicine and talk to your doctor or pharmacist.

Take special care with Colofac Tablets 135 mg

Check with your doctor or pharmacist before taking your medicine if:

  • You have developed new symptoms or your symptoms have become worse.
  • You have liver or kidney problems. If the above applies to you (or you are not sure), talk to your doctor or pharmacist before taking this medicine.

    Taking Colofac Tablets 135 mg with food and drink

    You can drink alcohol while you are taking Colofac ablets 135 mg.

    Taking other medicines

    No interactions with other medicines are known.

    Pregnancy and breast-feeding

    You should talk to your doctor or pharmacist before taking Colofac Tablets 135 mg if you are pregnant or might become pregnant. There is only limited information about the safety of Mebeverine for pregnant women. Your doctor may advise you to stop taking Colofac Tablets before you become pregnant or as soon as you know you are pregnant. Colofac Tablets should

    not be used during breast‑feeding.

    Driving and using machines

    This medicine is not likely to affect you being able to drive or use any tools or machines.

    Important information about some of the ingredients of Colofac Tablets 135 mg

    This medicine contains lactose and sucrose (types of sugar). If you have been told by your doctor that you cannot tolerate or digest some sugars (have an intolerance to some sugars), talk to your doctor before taking this medicine.

    50104157 CL5068

V1 MAY 2025

Date: Time:

DescriptionMebeverine Hydrochloride 135 mg 100
Leaflet/IFU - FoldedSite Barcode/ DataMatrix5068No. of colours1Page Count1/2
N/ASAP No.N/A
N/AN/A
N/A1
MA No.United Kingdomwith
Supplier SAP No.N/AN/A
New Supplier Code501041573D Render IDNAMain FontHelvetica Neue LT Pro10 pt
50098582158 x 315 mm10 pt
Mylan Laboratories SAS (Chatillon sur Chalaronne - FR)SPE 97885
Sign-offs

06 May 2025 12:24

3. How to take Colofac Tablets 135 mg

How to take Colofac Tablets 135 mg

  • Try to take the tablet twenty minutes before a meal ‑some people find their symptoms to be strongest after they have eaten.
  • Swallow the tablet whole with water. Do not chew the tablet.

How many Colofac Tablets 135 mg to take

Adults and the elderly:

  • Take 1 tablet 3 times a day
  • The number of tablets you take can be lowered if your symptoms improve
  • Do not take more than 3 tablets per day. Do not give Colofac Tablets 135 mg to children or adolescents younger than 18 years.

If you take more Colofac Tablets 135 mg than you should

If you or someone else takes too many Colofac Tablets 135 mg (an overdose), talk to a doctor or

go to a hospital straight away. Take the medicine pack with you.

If you forget to take Colofac Tablets 135 mg

If you miss a tablet, take it as soon as you remember. However, if it is nearly time for the next dose, skip the missed dose. Do not take a double dose to make up for a forgotten dose.

How to stop taking Colofac Tablets 135 mg

Do not stop taking the tablets without talking to your doctor, even if you feel better. If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Most people will not have problems, but some may get some side effects (unwanted effects or reactions).

If you get any of these serious side effects, stop taking the tablets. See a doctor at once:

  • Difficulty in breathing, swelling of face, neck, tongue or throat (severe allergic reactions)

These other effects are less serious. If they bother you talk to a pharmacist:

  • Skin rash, red itchy skin

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible

side effects not listed in this leaflet. You can also report side effects directly via the national

reporting system listed below.

In the UK:

The Yellow Card Scheme at:

www.mhra.gov.uk/yellowcard

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Colofac Tablets 135 mg

Keep out of the reach and sight of children.

  • You should lock this medicine in a cupboard or medicine cabinet.
  • Do not use the tablets after the expiry date which is printed on the carton and blister pack.
  • The expiry date refers to the last day of that month.
  • Do not store your tablets above 30°C.
  • Keep them in their original container. If your doctor stops your treatment, return unused tablets to a pharmacist. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. Further information

What Colofac Tablets 135 mg contain

Each tablet contains 135 mg mebeverine hydrochloride.

The tablets also contain lactose, starch (potato), povidone, talc, magnesium stearate, sucrose,

gelatin, acacia and carnauba wax.

What Colofac Tablets 135 mg look like and contents of the pack

Colofac Tablets 135 mg are white, round and sugar coated.

Each pack contains 100 tablets.

Marketing Authorisation Holder and Manufacturer

The Marketing Authorisation holder is:

Cooper Consumer Health B.V.

Verrijn Stuartweg 60,

1112AX Diemen – Netherlands

The Manufacturer is:

Mylan Laboratories SAS,

01400 Chatillon‑sur‑Chalaronne, France

This leaflet was last revised in July 2025.

®Registered trademark

50104157 CL5068

V1 MAY 2025

Date: Time:

DescriptionMebeverine Hydrochloride 135 mg 100
Leaflet/IFU - FoldedSite Barcode/ DataMatrix5068No. of colours1Page Count2/2
N/ASAP No.N/A
N/AN/A
N/A1
MA No.United Kingdomwith
Supplier SAP No.N/AN/A
New Supplier Code501041573D Render IDNAMain FontHelvetica Neue LT Pro10 pt
50098582158 x 315 mm10 pt
Mylan Laboratories SAS (Chatillon sur Chalaronne - FR)Keyline/Drawing No.SPE 97885
Sign-offs

06 May 2025 12:24

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 60682/0025

Last revision stated in the text: July 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Colofac tablets 135 mg

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Mebeverine
Strength 135 mg
Pharmaceutical form Oral tablet
Round white sugar coated tablets, with no superficial markings
How is it taken Oral
Excipients Lactose, starch (potato), povidone, talc, magnesium stearate, sucrose, gelatin, acacia, carnauba wax
Pack sizes 100 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 5 years
Storage Do not store above 30°C. Store in the original package.
Drug group (ATC) Synthetic anticholinergics, esters with tertiary amino group, ATC-Code: A03AA04
  1. A Alimentary tract and metabolism drugs
    1. A03 Drugs for functional gastrointestinal disorders
      1. A03A Drugs for functional gastrointestinal disorders
        1. A03AA Synthetic anticholinergics, esters with tertiary amino group for functional gastrointestinal disorders
          1. A03AA04 mebeverine
Marketing authorisation PL 60682/0025 (first authorised 14 March 1978)
Marketing authorisation holder Cooper Consumer Health B.V.
Codes GTIN 5099151007629 · BNF 01020000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.